Mwanzo1099 • HKG
add
Sinopharm Group Co Ltd
Bei iliyotangulia
$ 19.80
Bei za siku
$ 19.60 - $ 20.00
Bei za mwaka
$ 17.44 - $ 25.20
Thamani ya kampuni katika soko
61.98B HKD
Wastani wa hisa zilizouzwa
6.01M
Uwiano wa bei na mapato
6.37
Mgao wa faida
4.81%
Ubadilishanaji wa msingi
HKG
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (CNY) | Mac 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 147.27B | 1.20% |
Matumizi ya uendeshaji wa biashara | 7.19B | 3.80% |
Mapato halisi | 1.42B | -10.70% |
Kiwango cha faida halisi | 0.96 | -11.93% |
Mapato kwa kila hisa | — | — |
EBITDA | 3.91B | -13.51% |
Asilimia ya kodi ya mapato | 23.21% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (CNY) | Mac 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 48.91B | 3.62% |
Jumla ya mali | 413.07B | 2.78% |
Jumla ya dhima | 290.20B | 0.49% |
Jumla ya hisa | 122.86B | — |
hisa zilizosalia | 3.12B | — |
Uwiano wa bei na thamani | 0.81 | — |
Faida inayotokana na mali | 2.13% | — |
Faida inayotokana mtaji | 4.25% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (CNY) | Mac 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 1.42B | -10.70% |
Pesa kutokana na shughuli | -47.48B | -16.68% |
Pesa kutokana na uwekezaji | 256.12M | -38.43% |
Pesa kutokana na ufadhili | 22.15B | 4.94% |
Mabadiliko halisi ya pesa taslimu | -25.07B | -30.76% |
Mtiririko huru wa pesa | -24.53B | -79.75% |
Kuhusu
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Ilianzishwa
2003
Tovuti
Wafanyakazi
115,959
